7investing lead advisor Maxx Chatsko discusses the potential for cultured cannabinoids with Kevin Chen, co-founder and CEO of Hyasynth Bio. The industrial biotech company has a partnership with Organigram Holdings and recently became the first company in the world to bring cultured cannabinoids to market. What are the promises and pitfalls of scaling the new technology?

Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year.

Start your journey toward's financial independence: https://www.7investing.com/subscribe

Stop by our website to level-up your investing education:  https://www.7investing.com

Follow us on Social Media

► https://www.facebook.com/7investing/

► https://twitter.com/7investing

► https://instagram.com/7investing